539872 — Bajaj Healthcare Balance Sheet
0.000.00%
- IN₹14.83bn
- IN₹16.68bn
- IN₹5.43bn
- 67
- 15
- 28
- 25
Annual balance sheet for Bajaj Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 180 | 213 | 571 | 380 | 379 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,281 | 2,118 | 2,296 | 2,122 | 2,725 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,583 | 3,983 | 5,004 | 4,801 | 5,609 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,652 | 3,217 | 3,860 | 2,576 | 2,405 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,256 | 7,211 | 8,977 | 7,651 | 8,330 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,826 | 3,221 | 4,336 | 4,415 | 2,970 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,672 | 3,926 | 5,300 | 4,868 | 3,669 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,584 | 3,285 | 3,677 | 2,784 | 4,662 |
| Total Liabilities & Shareholders' Equity | 5,256 | 7,211 | 8,977 | 7,651 | 8,330 |
| Total Common Shares Outstanding |